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AMYOTROPHIC LATERAL SCLEROSIS AND FOOD INTAKE 
 
INTRODUCTION 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of unknown etiology. The 
origin of the disease is perhaps multifactorial and several genetic and environmental risk factors 
may be implicated. Many dietary factors have been investigated in order to verify their role in the 
onset or the progression of the disease. In recent years the role of vitamins, proteins, amino acids 
and other nutrients have been studied without showing a clear beneficial or adverse effect to the 
onset and/or the progression of the disease. Inadequate study designs, differing target 
populations, and lack of statistical power are possible explanations. In addition, there are no 
studies focusing on specific nutrients in ALS. On this background, we investigated dietary habits 
preceding ALS by performing a well-designed and adequately powered study in a representative 
sample of ALS patients and matched controls. The aim of the study was to verify if specific 
(combinations of) foods and nutrients could be risk factors or protective factors in the 
development of ALS. 
 
MATERIAL AND METHODS 
Patients with newly diagnosed ALS residing in three Italian administrative regions (Lombardy, 
Piedmont & Aosta valley, and Apulia; total population 18.629.052, 2014 census) were included in a 
European prospective observational study from February 2011 through January 2015 as part of 
the Euro-MOTOR collaboration. Euro-MOTOR was a network of European population-based 
registries from The Netherlands, Ireland and Italy aimed to investigate genetic and environmental 
risk factors for ALS using a case-control design. The details of the study design are illustrated 
elsewhere (D’Ovidio et al, ALS in press). 
As part of the Euro-MOTOR collaboration, an ancillary study was performed in Italy aimed to know 
the alimentary habits in ALS cases and controls. For the purpose of this study, patients were 
included if they were aged 18 or older and had definite, probable or possible ALS according to the 
El Escorial (EE) diagnostic classification (WFN Research Group on Neuromuscular Disorders. El 
Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J 
Neurol Sci 1994; 124(suppl): 96–107). We excluded individuals with other neurodegenerative 
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disorders, patients with percutaneous endoscopic gastrostomy for more than 1 year and patients 
with relatives affected by ALS. 
For each patient, a healthy control, matched for age (±5 years), sex and administrative region of 
residence, was selected by a general practitioner (1:1 ratio). After signed informed consent, cases 
and controls were interviewed by a trained investigator who filled a validated and reproducible 
food-frequency questionnaire (FFQ) (Decarli A, Franceschi S, Ferraroni M, et al. Validation of a 
food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for 
specific nutrients. Ann Epidemiol 1996;6:110-8.), which investigated habitual food intake before 
interview. In order to evaluate exposures preceding the onset of ALS symptoms, we excluded all 
subjects who had changed their diet in the 5 years before the study began. 
The following data were also recorded in a structured questionnaire: date of enrolment, sex, date 
of birth, region of residence, tobacco smoking, coffee and alcohol intake, and body mass index 
(BMI). For ALS patients, details were collected on the EE diagnostic category, site of onset of 
symptoms (bulbar, limbs, thoracic/respiratory), the Amyotrophic Lateral Sclerosis Functional 
Rating Scale (ALSFRS) score at study entry, date of diagnosis, and duration of symptoms at 
diagnosis. The recorded information was transferred from the questionnaires onto a centralized 
database for analysis. The study was approved by Ethic Committee of all participating centers. 
Daily intake of macronutrients (carbohydrates, i.e., sugars and starch, protein, fat, cholesterol, and 
fibers), micronutrients (vitamins and minerals), fatty acids, and total energy were estimated using 
an Italian food composition database (Gnagnarella P, Parpinel M, Salvini S, Franceschi S, Palli D, 
Boyle P. The update of the Italian food composition database. J Food Comp Analysis. 2004;17:509–
522). 
 
Statistical analysis 
Descriptive statistics for ALS cases and controls are reported as frequencies and percentages, 
means and standard deviations (SD), medians, interquartile ranges (IQR) or ranges, as appropriate. 
Differences between cases and controls were assessed using the chi-square test, or the Wilcoxon-
Mann-Whitney test. 
Food items included in the FFQ were combined into 21 groups: milk and yogurt; coffee and tea; 
white bread; whole bread; pasta and rice; soup; poultry; red meat; pork and processed meat; fish; 
eggs; cheese; raw vegetables; cooked vegetables; pulses; potatoes; citrus fruits; other fruits; 
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desserts; sugar; and alcohol. In order to define in greater detail the relationship between coffee 
and tea consumption and the risk of ALS, three subgroups were identified and assessed 
separately: coffee (decaffeinated excluded); decaffeinated coffee; tea.  
Food groups and nutrients were categorized into quartiles of intake in the entire sample (or using 
a more appropriate categorization for foods with low frequency of consumption). Conditional 
logistic regression models were used to evaluate the association between each food group, 
selected nutrients and the risk of ALS. All models were controlled for region, and sex (matching 
variables), and adjusted for age (5-year groups), BMI (<18.5; 18.5-24.9; 25-29.9; ≥30 kg/m2), 
tobacco smoking (ever; never), alcohol drinking (ever; never), coffee consumption (ever; never) 
and total energy intake (continuous). Interactions of food groups and nutrients with sex, site of 
onset and administrative region were also tested. 
Results are presented as odds ratios (OR), with 95% confidence intervals (95% CI). Missing data 
were present in less than 1% of subjects for each food item and were handled imputing the 
median intake of the corresponding missing food item, calculated on all available data. The 
significance level was set at 5%. All analyses were performed using the SAS statistical package 
(version 9.2, SAS Institute Inc, Cary, NC, USA). 
 
Ethical approval. The study protocal was approved by the Ethical Committees of all participating 
centers. All patients and controls signed an informed consent.  
 
RESULTS 
A total of 212 cases and 212 matched controls were included in the study. The sample included 
188 females and 236 males. The main characteristics of ALS cases are illustrated in Table 1. The 
mean (SD) age and disease duration at the time of diagnosis were 62.6 (10.4) years and 13.2 (12.9) 
months, respectively. Most patients had a spinal onset (74.1%), 24.1% had a bulbar onset, and 
only 1.9% had a respiratory onset. The commonest EE diagnostic categories were probable ALS 
(42.9%) and definite ALS (24.5%). The mean (SD) time from diagnosis at the date of interview was 
7.1 (5.5) months and the mean (SD) ALSFRS score was 37.3 (8.7).  
Cases and controls were evenly distributed as regards tobacco, alcohol, coffee and total energy 
intake, while cases had a lower BMI as compared to controls (Table 2). 
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A significant trend toward a risk reduction was found for coffee and tea (OR=0.29, 95% CI 0.14-
0.60 for the highest versus the lowest quartile of consumption), whole bread (OR=0.55, 95% CI 
0.31-0.99), raw vegetables (OR=0.25, 95% CI 0.13-0.52) and citrus fruits (OR=0.49, 95% CI 0.25-
0.97; Table 3). After separating coffee and tea into subgroups, a significant risk reduction was 
observed for decaffeinated coffee (OR=0.18, 95% CI 0.06-0.57) and for tea (OR=0.36, 95% CI 0.19-
0.67), but not for coffee (excluding decaffeinated coffee). A significant risk increase was observed 
for red meat (OR=2.96, 95% CI 1.46-5.99) and pork and processed meat (OR=3.87, 95% CI 1.86-
8.07). 
No significant association with the risk of ALS was found for total energy intake (Table 4). A 
significant inverse association was observed for vegetable fat (OR=0.25, 95% CI 0.11-0.57 for the 
highest versus the lowest quartile of intake), total folate (OR=0.41, 95% CI 0.18-0.91), and vitamin 
E (OR=0.40, 95% CI 0.18-0.92). 
A significantly increased risk was found for total protein (OR=2.96, 95% CI 1.08-8.10), animal 
protein (OR=2.91, 95% CI 1.33-6.38), sodium (OR=3.96, 95% CI 1.45-10.84) and zinc (OR=2.78, 95% 
CI 1.01-7.83). A significant risk increase was also found for the highest versus the lowest quartile of 
glutamic acid intake (OR=3.63, 95% CI 1.08-12.2), though in the absence of a linear trend in risk. 
No significant interactions were found with sex, site of onset and administrative region (data not 
shown). 
 
DISCUSSION 
In this case-control study including data from three Italian administrative regions, differences were 
noted for intake of some food items/nutrients between ALS patients and controls. ALS patients 
reported a lower intake of decaffeinated coffee, tea, whole bread, raw vegetables, citrus fruit, as 
well as of vegetable fats, folate, and vitamin E; conversely they reported a higher intake of (red 
and processed) meat and of proteins in general, as well as of sodium, zinc, and glutamic acid. 
A favorable role of Vitamin E on the risk of ALS is suggested by its cellular antioxidant role that was 
shown in transgenic mice expressing mutations in gene encoding the antioxidant enzyme CU/Zn 
superoxide dismutase (SOD), an animal model of ALS (ref). In animal models, Vitamin E was 
associated with a decreased incidence and progression of the disease, but had no effect on 
survival; in addition, several cell experiments revealed a neuroprotective  effect of alpha-
tocopherol in ALS (D Allan Butterfield et al,  Nutritional Neuroscienze 2002, vol 5). However, the 
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use of antioxidant agents had no apparent beneficial effect on survival nor on disease progression 
in ALS patients (Orrell et al, ALS and FT disease, 10/07/2009). Our findings suggest that the effects 
of vitamin E on motor neurons may differ according to the modalities of intake (food vs. drug). The 
benefits of vitamin E present in the diet on ALS risk may depend on its possible interaction with 
other food components.  
We found a significant inverse association between ALS, tea and decaffeinated coffee. Other 
studies investigated the association between coffee (caffeinated beverages, tea) and ALS risk or 
progression. A cohort study also observed a protective role of tea on ALS (Morozova et all 2008 
Epidemiology), but, in contrast with our results, that study found that decaffeinated coffee was 
associated with an increased risk of ALS. An inverse association with coffee was found in an Italian 
case-control study (Coffee and amyotrophic lateral sclerosis: a possible preventive role. Beghi E, 
Pupillo E, Messina P, Giussani G, Chiò A, Zoccolella S, Moglia C, Corbo M, Logroscino G; EURALS 
Group. Am J Epidemiol. 2011 Nov 1;174(9):1002-8). However, that study was unable to identify 
the specific role of caffeine or other components of caffeinated beverages.  The role of coffee was 
also investigated in a pooled-analysis of five cohorts in the US (Elinor Fondell et al, Amyotroph 
Lateral Scler Frontotemporal Degener 2015 September ; 16). In line with our findings, that study 
did not confirm an association between caffeine or caffeinated beverages and the risk of ALS. Both 
caffeinated and decaffeinated coffee have protective effects against neurodegeneration (Kim & 
Lee, Coffee Volume, pp 423-427). Coffee has been shown to exhibit protective effects against 
Parkinson and Alzheimer disease (Barranco Quintana et al, 2007; Ross et al, 2000). Chlorogenic 
acid, caffeic acid, kahweol and trigonelline, may be involved as they also contribute to the 
neuropharmacological action of coffee. Caffeic acid, with ferulic and p-coumaric acid, is a phenolic 
acid interacting with lipid membranes and, as such, has beneficial effects through the prevention 
of neurodegenerative diseases (Chapter 89 Coffee Volume). Chlorogenic acid has antioxidant 
activity and is able to scavenge free radicals and interrupt radical chain reactions (Chapter  87 
Coffee Volume). Kawheol, a coffee diterpene, has anti-inflammatory properties, modulates nitric 
oxide synthesis, and protects against oxidative stress (Chapter 70 Coffee Volume). The 
neuroprotective activity of these agents has been mostly documented in Parkinson disease but the 
possibility exists of a similar action in patients with ALS. 
We also found an inverse association between folate intake and ALS. Folate deficiency is present in 
a variety neurological disorders, including Alzheimer disease, Parkinson disease and ALS (Mizrahi 
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et al, 2003). A study (MAYA DUBEY and Thomas Shea, Nutritional Neuroscience, October 2007) has 
shown that folate deprivation increases the impact of arsenic neurotoxicity. As the toxicity of 
arsenic could be decreased with antioxidants intake (MAYA DUBEY and Thomas Shea, Nutritional 
Neuroscience, October 2007), an antioxidant deficit could enhance the toxic effects of arsenic in 
predisposed individuals resulting in neurodegeneration. The combined intake of folate and vitamin 
E together may have a strong effect against oxidative stress and ultimately decrease the risk of 
ALS. 
We also investigated the role of whole bread in ALS onset and found an inverse association. This 
finding was confirmed by a cohort study (Morozova 2008, Epidemiology)  in patients aged 65 or 
older, a population largely overlapping our sample. However, we did not find an inverse 
association between fibers and ALS. Fibers have a low concentration of markers of inflammation – 
which has a key role in the pathogenesis of ALS (Philips t et al, Lancet Neurol 2011) – (qi l et al, 
Diabetes care 2006; Chuang SC et al, Biomarkers 2011) and a high fiber intake has been associated 
with a lower risk of ALS (Nelson LM et al, Am J Epidemiol 2000). We found a borderline increased 
association between glutamic acid and ALS. Glutamate is a cytotoxic substance involved in the 
pathogenesis of ALS (Morozova 2008, Epidemiology). The overexcitation of glutamate receptors 
leads to the elevation of the intracellular calcium causing the selective neuron death that is the 
primary cause of ALS. Glutamate is available in food containing protein, tomatoes, mushrooms, 
milk and cheese, but the role of dietary glutamate intake in ALS is still unclear. Monosodium 
glutamate use is frequent in precooked food and in sausages, that are frequently used. Glutamate 
is metabolized as glutamic acid. We still do not known to what extent glutamate or glutamic acid 
are involved in ALS process. The prospective cohort study by Morozova et al (2008) aimed to 
investigate the role of diet in the onset of cancer and other disorders, failed to show an 
association between red meat, vegetables or other products that are the primary source of 
glutamate and ALS onset while a strong inverse association was found for chicken consumption. 
The different study design may explain the differences between that study, that did not 
investigate the role of nutrients, and ours.  
In agreement with us, a population-based case-control study (Nelson 2000 AJE) and a cohort study 
(Morozova 2008, Epidemiology; Fondell 2014 AJE) reported an inverse association between fruits 
and vegetables intake and risk of ALS. Fruits were also investigated in Japanese  case-control 
studies. Jin et al (Jin 2014 Nutritional Neuroscience) and Okamoto et Al (Okamoto 2008 
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Neuroepidemiology) reported a significant  inverse association between fruit intake and risk of 
ALS. Fruits and vegetables are rich of antioxidant vitamins and minerals (Van Duyn et al J Am Diet 
Assoc 2000; 100: 1511-21, Binazzi et Al ALSFTD 2009). An increased intake of fruits and vegetables 
may thus protect against oxidative stress as being free radical scavengers.   
In addition, high intake of vegetables and fruits and low intake of processed meat were included 
among “Alzheimer disease protective” patterns (Berti et al, J Nutr Health Aging 2015; 19:413).  
We found an increased risk of ALS for pork/processed meat, red meat, zinc and sodium. To our 
knowledge, these are no studies demonstrating the association of this food groups and nutrients 
with ALS. We found a significant linear correlation (above 0.5) between zinc and red meats (0.65), 
between zinc and pork/processed meats (0.54), and between sodium and processed meats (0.55).  
Our study has several strengths. First, we have looked at foods or food groups using a validated 
and reproducible FFQ and an Italian food composition database (Gnagnarella P, Parpinel M, Salvini 
S, Franceschi S, Palli D, Boyle P. The update of the Italian food composition database. J Food Comp 
Analysis. 2004;17:509–522; Salvini S, Parpinel M, Gnagnarella P et al. Milan, Italy: Istituto Europeo 
di Oncologia,1998). We have been also able to estimate the intake of selected nutrients, and thus 
to verify which specific elements could or could not be involved in the disease process. Second, 
this is the first population based case-control study with a fairly large sample size; controls were 
from general practitioners and were not family members, i.e. individuals with similar dietary 
habits. Third, we investigated the role of food intake during health status and in patients without 
percutaneous endoscopic gastrostomy.  
The study has also limitations. This is an Italian study and, as such, the results are a reflection of 
the Italian diet, which differs from other diets mostly in the use of olive oil, coffee and vegetables. 
These findings thus require confirmation in other geographic areas where the alimentary habits 
are different from ours. Another limitation is inherent in the case-control design, which is 
subjected to recall bias. A third limitation is the possibility of reverse causation. We tried to 
investigate unchanged alimentary habits and excluded diets changed in the preceding five years. 
However, as the time of disease onset is unknown, we cannot exclude that dietary changes 
occurred during the  course of the disease. 
 
In conclusion, our findings support the hypothesis that some foods/nutrients may be risk factors 
and others protective factors for ALS. However, a definite answer to this controversial issue could 
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be provided only by a larger and specific evaluation of few nutrients matched with specific genetic 
tests. 
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Table 1. Characteristics of ALS cases (n=212) 
  N % 
Site of onset   
Bulbar 51 24.1 
Spinal 157 74.1 
Thoracic/respiratory 4 1.9 
El Escorial category   
Definite 52 24.5 
Possible 48 22.71 
Probable 91 42.9 
Probable laboratory 
supported 21 9.9 
   
 Mean SD 
Age at diagnosis 62.6 10.4 
Age at onset 61.5 10.3 
Disease duration at 
diagnosis (months) 13.2 12.9 
Time from diagnosis 7.1 5.5 
ALSFRS 37.3 8.7 
 
SD: standard deviation. 
ALSFRS: ALS Functional Rating Scale 
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Table 2. Distribution of ALS cases (n=212) and controls (n=212) according to selected variables 
  ALS  Controls  
  N %  N % p-value 
       
Region*       
Lombardy 87 41.0  87 41.0  
Piedmont 87 41.0  87 41.0  
Puglia 38 17.9  38 17.9  
Age (years)*       
<50  25 11.8  24 11.3  
50-54  22 10.4  20 9.4  
55-59  24 11.3  19 9.0  
60-64  42 19.8  37 17.5  
65-69  44 20.8  48 22.6  
70-74  30 14.1  33 15.6  
75+  25 11.8  31 14.6  
Sex*       
Female 94 44.3  94 44.3  
Male 118 55.7  118 55.7  
BMI (kg/m2)      0.0479 
Underweight (<18.5) 14 6.6  6 2.8  
Normal (18.5 - 24.9) 115 54.3  98 46.2  
Overweight (25 - 29.9) 63 29.7  80 37.7  
Obese (≥30) 20 9.4  28 13.2  
Tobacco smoking      0.5586 
Never 94 44.3  100 47.2  
Ever 118 55.7  112 52.8  
Alcohol drinking      0.6663 
Never 62 29.3  58 27.4  
Ever 150 70.7  154 72.6  
Coffee consumption      0.1791 
Never 30 14.1  21 9.9  
Ever 182 85.9  191 90.1  
 Median IQR  Median IQR  
Total energy intake 
(kcal) 1856 1571 - 2239  1892 1552 - 2223 0.8732 
 
*Matching variables 
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BMI: Body Mass index 
IQR: interquartile range. 
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Table 3. Food groups: odds ratios of ALS according to quartiles of weekly consumption 
    Quartile of intake* p-value 
for 
trend    
 2  3  4 
Food group Median IQR  OR 95% CI  OR 95% CI  OR 95% CI 
Milk and yogurt 8.8 5.0 - 10.8  1.07 0.61 - 1.89  0.93 0.48 - 1.77  1.10 0.61 - 1.99 0.8663 
Coffee and tea 10.5 5.3 - 15.8  0.62 0.35 - 1.09  0.98 0.52 - 1.85  0.29 0.14 - 0.60 0.0079 
Coffee (decaffeinated excluded) 7.5 5.3 - 13.5  1.10 0.50 - 2.43  0.69 0.40 - 1.19  1.19 0.67 - 2.12 0.9482 
Decaffeinated coffee1 0.0 0.0 - 0.0  0.37 0.13 - 1.03  0.18 0.06 - 0.57    0.0007 
Tea2 0.0 0.0 - 1.0  0.86 0.46 - 1.59  0.36 0.19 - 0.67    0.0021 
White bread 9.0 5.7 - 15.5  0.69 0.38 - 1.24  0.84 0.44 - 1.61  0.91 0.45 - 1.82 0.8710 
Whole bread3 0.0 0.0 - 1.8  0.57 0.30 - 1.09  0.55 0.31 - 0.99    0.0323 
Pasta and rice 4.9 3.4 - 6.9  1.38 0.74 - 2.57  1.16 0.60 - 2.24  1.28 0.64 - 2.58 0.6423 
Soup 1.4 0.6 - 3.0  1.37 0.79 - 2.39  1.31 0.72 - 2.37  1.54 0.81 - 2.95 0.2073 
Poultry 1.8 1.0 - 2.5  0.93 0.50 - 1.75  0.82 0.46 - 1.47  1.83 0.96 - 3.48 0.1844 
Red meat 2.2 1.4 - 3.2  1.74 0.94 - 3.22  1.55 0.84 - 2.85  2.96 1.46 - 5.99 0.0060 
Pork and processed meat 2.3 1.3 - 3.4  1.44 0.75 - 2.77  1.60 0.83 - 3.07  3.87 1.86 - 8.07 0.0006 
Fish 2.0 1.3 - 2.8  1.08 0.59 - 1.97  1.21 0.67 - 2.22  0.69 0.37 - 1.30 0.3946 
Eggs 1.0 0.8 - 2.0  0.60 0.34 - 1.08  0.82 0.47 - 1.45  0.64 0.32 - 1.28 0.3406 
Cheese 2.8 1.5 - 4.3  0.73 0.38 - 1.43  0.97 0.53 - 1.77  0.55 0.27 - 1.10 0.2221 
Raw vegetables 7.5 4.4 - 11.3  0.46 0.24 - 0.86  0.56 0.30 - 1.05  0.25 0.13 - 0.52 0.0005 
Cooked vegetables 4.4 3.0 - 6.7  0.91 0.49 - 1.68  0.67 0.36 - 1.22  0.79 0.43 - 1.48 0.3119 
Pulses 1.0 0.5 - 2.0  1.19 0.67 - 2.14  0.88 0.48 - 1.62  1.24 0.58 - 2.63 0.9732 
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Potatoes 1.3 1.0 - 2.0  0.95 0.44 - 2.05  0.64 0.36 - 1.13  1.18 0.66 - 2.12 0.8969 
Citrus fruits 6.0 3.0 - 7.0  0.44 0.23 - 0.86  0.41 0.22 - 0.77  0.49 0.25 - 0.97 0.0198 
Other fruits 20.0 14.5 - 28.0  0.81 0.45 - 1.47  0.52 0.29 - 0.93  0.78 0.37 - 1.60 0.1339 
Desserts 6.3 3.0 - 9.8  0.77 0.42 - 1.41  0.97 0.52 - 1.82  1.43 0.76 - 2.68 0.2167 
Sugar 7.5 5.3 - 13.5  1.09 0.60 - 1.99  1.01 0.57 - 1.79  1.04 0.58 - 1.89 0.9574 
Alcohol 7.0 0.0 - 14.0  0.67 0.34 - 1.32  0.76 0.37 - 1.57  0.49 0.22 - 1.08 0.1310 
 
All models were controlled for region, age and sex (matching variables), and adjusted for BMI (<18.5; 18.5-24.9; 25-29.9; ≥30 kg/m2), tobacco 
smoking (ever; never), alcohol drinking (ever; never), coffee consumption (ever; never) and total energy intake (continuous). 
IQR: interquartile range; OR: odds ratio; CI: confidence interval. 
*reference category: first quartile; 
1 reference category: 0 cups; category 2: <7 cups per week; category 3: ≥7 cups per week; 
2 reference category: 0 cups; category 2: <3 cups per week; category 3: ≥3 cups per week; 
3 reference category: 0 portions per week; category 2: 1-4 portions per week; category 3: >4 portions per week 
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Table 4. Total energy and selected nutrients: odds ratios of ALS according to quartiles of daily intake 
 
   Quartile of intake* p-value 
for 
trend   
 2  3  4 
Mean SD  OR 95% CI  OR 95% CI  OR 95% CI 
Energy (kcal) 1942.5 557.5  1.25 0.69-2.25  1.01 0.54-1.89  1.15 0.59-2.26 0.8680 
Macronutrients             
Total protein (g) 77.9 22.4  2.35 1.22-4.53  2.31 1.09-4.89  2.96 1.08-8.10 0.0437 
Animal protein (g) 48.7 16.4  1.93 0.99-3.76  2.25 1.17-4.33  2.91 1.33-6.38 0.0070 
Vegetable protein (g) 29.2 9.9  1.85 0.94-3.64  1.25 0.59-2.61  1.98 0.64-6.17 0.4958 
Available carbohydrates (g) 251.3 80.7  2.15 1.06-4.37  1.71 0.77-3.79  2.21 0.70-6.93 0.2925 
Soluble carbohydrates (g) 90.4 41.9  0.57 0.31-1.04  0.84 0.44-1.63  1.14 0.53-2.47 0.6379 
Starch (g) 160.8 59.9  1.23 0.62-2.45  0.93 0.47-1.86  1.21 0.47-3.14 0.9720 
Fibers (g) 23.3 9.4  0.78 0.42-1.45  0.69 0.35-1.35  0.80 0.35-1.85 0.5034 
Total fat (g) 66.1 20.6  0.74 0.40-1.39  1.01 0.48-2.15  0.48 0.17-1.33 0.3243 
Animal fat (g) 35.7 13.5  0.72 0.37-1.41  2.11 1.05-4.24  1.56 0.68-3.59 0.0529 
Vegetable fat (g) 30.4 11.5  0.85 0.46-1.55  0.62 0.31-1.21  0.25 0.11-0.57 0.0019 
Cholesterol (mg) 291.8 101.8  1.10 0.57-2.13  1.26 0.64-2.48  1.91 0.88-4.16 0.0977 
Fatty acids             
Saturated fatty acids (g) 21.8 7.6  0.59 0.31-1.16  1.10 0.51-2.38  0.86 0.36-2.07 0.9949 
Monounsaturated fatty acids (g) 30.7 9.8  0.72 0.37-1.39  0.89 0.45-1.76  0.50 0.19-1.28 0.3074 
      Oleic acid (g) 28.9 9.3  0.55 0.29-1.06  0.76 0.39-1.50  0.45 0.18-1.14 0.2196 
Polyunsaturated fatty acids (g) 9.4 3.5  0.90 0.46-1.77  0.76 0.37-1.56  0.45 0.17-1.19 0.1298 
      Linoleic acid (g) 7.8 3.0  1.09 0.55-2.15  0.95 0.47-1.94  0.54 0.20-1.42 0.2812 
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      Linolenic acid (g) 1.1 0.4  0.61 0.32-1.14  0.68 0.34-1.37  0.63 0.25-1.57 0.3355 
      Other polyunsaturated fatty acids (g) 0.5 0.2  1.55 0.82-2.95  1.97 1.03-3.80  1.75 0.90-3.43 0.0870 
Micronutrients             
Retinol (μg) 1190.8 833.5  0.75 0.42-1.32  0.70 0.38-1.32  0.90 0.48-1.69 0.7380 
Vitamin B1 (mg) 0.9 0.3  1.45 0.77-2.72  1.79 0.86-3.72  1.54 0.58-4.09 0.2622 
Vitamin B2 (mg) 1.4 0.4  0.96 0.48-1.90  0.93 0.47-1.85  0.71 0.31-1.65 0.4731 
Vitamin B6 (mg) 2.2 0.7  1.30 0.69-2.47  1.91 0.96-3.80  1.79 0.74-4.33 0.1145 
Vitamin B3 (mg) 19.6 6.1  1.54 0.79-3.00  1.92 0.97-3.80  1.88 0.79-4.48 0.1159 
Total folate (μg) 304.5 103.5  0.95 0.52-1.72  0.65 0.33-1.30  0.41 0.18-0.91 0.0334 
Vitamin C (mg) 167.2 92.1  0.93 0.50-1.73  0.83 0.43-1.61  0.90 0.43-1.87 0.6944 
Vitamin D (μg) 2.8 1.3  0.81 0.44-1.50  1.48 0.76-2.90  0.84 0.43-1.66 0.9724 
Vitamin E (mg) 10.7 3.7  0.87 0.49-1.56  0.70 0.34-1.31  0.40 0.18-0.92 0.0374 
Iron (mg) 12.7 4.0  2.33 1.16-4.66  0.85 0.41-1.74  1.05 0.37-2.96 0.5236 
Calcium (mg) 752.6 270.4  0.98 0.53-1.82  0.90 0.45-1.79  0.72 0.34-1.54 0.3955 
Sodium (mg) 1702.9 653.1  1.23 0.65-2.34  2.06 0.96-4.42  3.96 1.45-10.84 0.0058 
Potassium (mg) 3463.3 1090.9  1.22 0.65-2.31  1.28 0.62-2.66  1.03 0.40-2.67 0.8402 
Phosphorus (mg) 1280.3 359.1  1.14 0.61-2.14  1.44 0.67-3.12  0.67 0.23-1.92 0.8423 
Zinc (mg) 10.3 3.0  2.21 1.15-4.25  2.63 1.21-5.72  2.78 1.01-7.83 0.0274 
Glutamic acid (mg) 16153.5 4670.1  2.63 1.30-5.33  2.09 0.92-4.73  3.63 1.08-12.20 0.0684 
Beta-carotene equivalents (μg) 4254.85 2376.19  1.01 0.57-1.80  0.72 0.38-1.36  0.63 0.33-1.22 0.1126 
 
All models were controlled for region, age and sex (matching variables), and adjusted for BMI (<18.5; 18.5-24.9; 25-29.9; ≥30 kg/m2), tobacco 
smoking (ever; never), alcohol drinking (ever; never), coffee consumption (ever; never) and total energy intake (continuous). 
SD: standard deviation; OR: odds ratio; CI: confidence interval. 
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